Skip to content

Hiroshima NT-proBNP study in hemodialysis patients (HINT)

Hiroshima NT-proBNP study in hemodialysis patients (HINT) - NT-proBNP in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007656
Enrollment
1000
Registered
2012-04-03
Start date
2012-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal failure

Interventions

None listed

Sponsors

Department of Nephrology, Hiroshima University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who undergo hemodialysis three times a week

Exclusion criteria

Exclusion criteria: Patients who are younger than 20 years old, peritoneal dialysis patients, do not undergo hemodialysis three times a week, have a poor prognosis cancer, have a severe infectious disease, and show symptoms of heart failure at rest

Design outcomes

Primary

MeasureTime frame
death

Secondary

MeasureTime frame
Cardiovascular event

Countries

Japan

Contacts

Public ContactDOI, Shigehiro

Hiroshima University Hospital Department of Blood Purification

sdoi@hiroshima-u.ac.jp082-257-5960

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026